Chen T, Liu G, Chen S, Zhang F, Ma S, Bai Y
Acta Pharm Sin B. 2025; 15(1):467-483.
PMID: 40041899
PMC: 11873566.
DOI: 10.1016/j.apsb.2024.07.013.
Sokal A, Mruczek P, Niedoba M, Dewalska A, Stocerz K, Kadela-Tomanek M
Molecules. 2025; 30(4).
PMID: 40005270
PMC: 11857933.
DOI: 10.3390/molecules30040960.
Albukhari T, Bagadood R, Bokhari B, Filimban W, Sembawa H, Nasreldin N
Biomedicines. 2025; 13(2).
PMID: 40002685
PMC: 11853687.
DOI: 10.3390/biomedicines13020271.
Lee Y, Jeong E, Kim Y, Park J, Yoon J, Lee Y
Aging (Albany NY). 2025; 17(2):497-523.
PMID: 39992207
PMC: 11892931.
DOI: 10.18632/aging.206207.
Klasik-Ciszewska S, Londzin P, Grzywnowicz K, Borymska W, Zych M, Kaczmarczyk-Zebrowska I
Nutrients. 2025; 17(2).
PMID: 39861446
PMC: 11767798.
DOI: 10.3390/nu17020316.
The Counteracting Effect of Chrysin on Dietary Fructose-Induced Metabolic-Associated Fatty Liver Disease (MAFLD) in Rats with a Focus on Glucose and Lipid Metabolism.
Campanher G, Andrade N, Lopes J, Silva C, Pena M, Rodrigues I
Molecules. 2025; 30(2).
PMID: 39860248
PMC: 11768066.
DOI: 10.3390/molecules30020380.
Cardiovascular protective effects of natural flavonoids on intestinal barrier injury.
Zhou P, Xu H, Wang L
Mol Cell Biochem. 2025; .
PMID: 39820766
DOI: 10.1007/s11010-025-05213-2.
White adipose tissues and skeletal muscles as a target of chrysin during the treatment of obesity in rats.
Hassan O, Megahed M, Ghazal N
Sci Rep. 2025; 15(1):1011.
PMID: 39762333
PMC: 11704229.
DOI: 10.1038/s41598-024-82820-x.
Apigenin as an emerging hepatoprotective agent: current status and future perspectives.
Wang C, Feng X, Li W, Chen L, Wang X, Lan Y
Front Pharmacol. 2025; 15:1508060.
PMID: 39749193
PMC: 11693974.
DOI: 10.3389/fphar.2024.1508060.
5,7-Dihydroxyflavone acts on eNOS to achieve hypotensive effects in spontaneously hypertensive rats.
Shen Z, Ye T, Chen B, Wan C, Lu X, Chen T
Sci Rep. 2025; 15(1):594.
PMID: 39747252
PMC: 11695686.
DOI: 10.1038/s41598-024-84259-6.
Compare and Contrast of the Cellular Actions of Related Flavonoids, Apigenin and Chrysin.
Keefe P, Puthanveetil P
Nutrients. 2024; 16(23).
PMID: 39683588
PMC: 11644185.
DOI: 10.3390/nu16234195.
Exploring the relationship between metabolite composition and the cold/hot properties ascribed in traditional Chinese medicine by mass spectral molecular networking - A pilot study.
Su C, Cheng Y, Lai K, Chang Y, Sun C, Tu P
J Food Drug Anal. 2024; 30(3):402-416.
PMID: 39666294
PMC: 9635908.
DOI: 10.38212/2224-6614.3425.
Natural pigments derived from plants and microorganisms: classification, biosynthesis, and applications.
Tang Q, Li Z, Chen N, Luo X, Zhao Q
Plant Biotechnol J. 2024; 23(2):592-614.
PMID: 39642082
PMC: 11772333.
DOI: 10.1111/pbi.14522.
Research Progress of in the Treatment of Gastrointestinal Cancer.
Wang L, Ni B, Wang J, Zhou J, Wang J, Jiang J
Integr Cancer Ther. 2024; 23:15347354241302049.
PMID: 39610320
PMC: 11605761.
DOI: 10.1177/15347354241302049.
Engineering an Escherichia coli strain for enhanced production of flavonoids derived from pinocembrin.
Hanko E, Robinson C, Bhanot S, Jervis A, Scrutton N
Microb Cell Fact. 2024; 23(1):312.
PMID: 39558341
PMC: 11575205.
DOI: 10.1186/s12934-024-02582-z.
Eco-Friendly Analytical Approach for Sensitive Spectrofluorimetric Determination of the Flavonoid Chrysin in Capsules and Human Plasma.
El-Aziz H, Hammouda N, Belal F, Elama H
J Fluoresc. 2024; .
PMID: 39446181
DOI: 10.1007/s10895-024-03962-9.
3'-8″- Biflavones: A Review of Their Structural Diversity, Natural Occurrence, Role in Plants, Extraction and Identification.
Samec D, Jurcevic Sangut I, Karalija E, Sarkanj B, Zelic B, Salic A
Molecules. 2024; 29(19).
PMID: 39407564
PMC: 11478198.
DOI: 10.3390/molecules29194634.
Induction of immunogenic cell death and enhancement of the radiation-induced immunogenicity by chrysin in melanoma cancer cells.
Jafari S, Ardakan A, Aghdam E, Mesbahi A, Montazersaheb S, Molavi O
Sci Rep. 2024; 14(1):23231.
PMID: 39369019
PMC: 11455848.
DOI: 10.1038/s41598-024-72697-1.
Therapeutic Potential of Natural Resources Against Endometriosis: Current Advances and Future Perspectives.
Gu X, Zhou H, Miao M, Hu D, Wang X, Zhou J
Drug Des Devel Ther. 2024; 18:3667-3696.
PMID: 39188919
PMC: 11345706.
DOI: 10.2147/DDDT.S464910.
Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges.
Yang Y, Wang X
Front Pharmacol. 2024; 15:1419384.
PMID: 39166109
PMC: 11333238.
DOI: 10.3389/fphar.2024.1419384.